BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35192058)

  • 1. Duration of palliative care involvement and immunotherapy treatment near the end of life among patients with cancer who died in-hospital.
    Auclair J; Sanchez S; Chrusciel J; Hannetel L; Frasca M; Economos G; Habert-Dantigny R; Bruera E; Burucoa B; Ecarnot F; Colombet I; Barbaret C
    Support Care Cancer; 2022 Jun; 30(6):4997-5006. PubMed ID: 35192058
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance status and end-of-life care among adults with non-small cell lung cancer receiving immune checkpoint inhibitors.
    Petrillo LA; El-Jawahri A; Nipp RD; Lichtenstein MRL; Durbin SM; Reynolds KL; Greer JA; Temel JS; Gainor JF
    Cancer; 2020 May; 126(10):2288-2295. PubMed ID: 32142165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune Checkpoint Inhibitors and Palliative Care at the End of Life: An Irish Multicentre Retrospective Study.
    O'Sullivan HM; Conroy M; Power DG; Bambury RM; O'Mahony D; Collins DC; O'Leary MJ; O'Reilly S
    J Palliat Care; 2022 Feb; ():8258597221078391. PubMed ID: 35129002
    [No Abstract]   [Full Text] [Related]  

  • 4. Referral Characteristics of Palliative Care Service in Patients With Advanced Non-Small Cell Lung Cancer in a Tertiary Cancer Center.
    Gu X; Chen M; Liu M; Zhang Z; Zhao W; Cheng W
    Am J Hosp Palliat Care; 2020 Apr; 37(4):266-271. PubMed ID: 31378075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Palliative Systemic Therapy Given near the End of Life for Metastatic Non-Small Cell Lung Cancer.
    Beaudet MÉ; Lacasse Y; Labbé C
    Curr Oncol; 2022 Feb; 29(3):1316-1325. PubMed ID: 35323312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immune Checkpoint Inhibitor Use Near the End of Life: A Single-Center Retrospective Study.
    Glisch C; Saeidzadeh S; Snyders T; Gilbertson-White S; Hagiwara Y; Lyckholm L
    J Palliat Med; 2020 Jul; 23(7):977-979. PubMed ID: 31702481
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of palliative care in relapsed and metastatic head and neck cancer patients in a single ESMO integrated oncology and palliative care centre.
    Espeli VG; Fusi-Schmidhauser T; Mangan D; Gamondi C
    Eur Arch Otorhinolaryngol; 2022 Dec; 279(12):5897-5902. PubMed ID: 35821270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of early palliative interventions on the outcomes of care for patients with non-small cell lung cancer.
    Nieder C; Tollåli T; Haukland E; Reigstad A; Flatøy LR; Engljähringer K
    Support Care Cancer; 2016 Oct; 24(10):4385-91. PubMed ID: 27209479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Palliative care and imaging utilisation for patients with cancer.
    Raghavan K; Copeland TP; Rabow M; Ladenheim M; Marks A; Pantilat SZ; O'Riordan D; Seidenwurm D; Franc B
    BMJ Support Palliat Care; 2022 Dec; 12(e6):e813-e820. PubMed ID: 30826736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Team-Based Hospice Referrals: A Potential Quality Metric for Lung Cancer in the Immunotherapy Era.
    Lycan TW; Buckenheimer A; Ruiz J; Russell G; Dothard AS; Ahmed T; Grant S; Grey C; Petty WJ
    Am J Hosp Palliat Care; 2023 Jan; 40(1):10-17. PubMed ID: 35512681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outpatient palliative care and thoracic medical oncology: Referral criteria and clinical care pathways.
    Caraceni A; Lo Dico S; Zecca E; Brunelli C; Bracchi P; Mariani L; Garassino MC; Vitali M
    Lung Cancer; 2020 Jan; 139():13-17. PubMed ID: 31704278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent Immune Checkpoint Inhibitors and Stereotactic Radiosurgery for Brain Metastases in Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma.
    Chen L; Douglass J; Kleinberg L; Ye X; Marciscano AE; Forde PM; Brahmer J; Lipson E; Sharfman W; Hammers H; Naidoo J; Bettegowda C; Lim M; Redmond KJ
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):916-925. PubMed ID: 29485071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemotherapy use in end-of-life digestive cancer patients: a retrospective AGEO observational study.
    Lapeyre-Prost A; Perkins G; Vallee M; Pozet A; Tougeron D; Maillet M; Locher C; Dreanic J; Legoux JL; Lièvre A; Lecaille C; Sabate JM; Mary F; Bonnetain F; Jaulmes-Bouillot H; Behal F; Landi B; Taieb J
    Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101709. PubMed ID: 33930588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Magnitude and Effects of Early Integration of Palliative Care Into Oncology Service Among Adult Advanced Cancer Patients at a Tertiary Care Hospital.
    Ghabashi EH; Sharaf BM; Kalaktawi WA; Calacattawi R; Calacattawi AW
    Cureus; 2021 May; 13(5):e15313. PubMed ID: 34211813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adverse impact of bone metastases on clinical outcomes of patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitors.
    Li X; Wang L; Chen S; Zhou F; Zhao J; Zhao W; Su C
    Thorac Cancer; 2020 Oct; 11(10):2812-2819. PubMed ID: 32779372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive impact of antibiotics in patients with advanced non small-cell lung cancer receiving immune checkpoint inhibitors : Antibiotics immune checkpoint inhibitors in advanced NSCLC.
    Schett A; Rothschild SI; Curioni-Fontecedro A; Krähenbühl S; Früh M; Schmid S; Driessen C; Joerger M
    Cancer Chemother Pharmacol; 2020 Jan; 85(1):121-131. PubMed ID: 31745593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the utilization of the decision to implement a palliative goal for the treatment of cancer patients during the last year of life at Helsinki University Hospital: a historic cohort study.
    Hirvonen OM; Leskelä RL; Grönholm L; Haltia O; Rissanen A; Tyynelä-Korhonen K; Rahko EK; Lehto JT; Saarto T
    Acta Oncol; 2019 Dec; 58(12):1699-1705. PubMed ID: 31742490
    [No Abstract]   [Full Text] [Related]  

  • 18. Palliative Care Interventions and End-of-Life Care for Patients with Metastatic Breast Cancer: A Multicentre Analysis.
    Lucchi E; Berger F; Milder M; Commer JM; Morin S; Capodano G; Thomaso M; Fogliarini A; Bremaud N; Henry A; Mastroianni B; Chvetzoff G; Bouleuc C
    Oncologist; 2024 May; 29(5):e708-e715. PubMed ID: 38387031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of Specialty Palliative Care Utilization Among Patients Receiving Palliative Radiation Therapy.
    Chen JJ; Rawal B; Krishnan MS; Hertan LM; Shi DD; Roldan CS; Huynh MA; Spektor A; Balboni TA
    J Pain Symptom Manage; 2021 Aug; 62(2):242-251. PubMed ID: 33383147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of end-of-life care for patients with metastatic non-small-cell lung cancer in general wards and palliative care units in Japan.
    Nakano K; Yoshida T; Furutama J; Sunada S
    Support Care Cancer; 2012 Apr; 20(4):883-8. PubMed ID: 22246597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.